A recent study by the All India Institute of Medical Sciences Patna has revealed a strong connection between brain injury and deaths caused by heatstroke. The research highlights how extreme heat can damage a critical part of the brain responsib...
Granules India reported a strong finish to FY26, with Granules India Q4 profit rising 33 percent year-on-year to Rs 201 crore. The company’s performance reflects solid demand, improved margins, and steady execution across key business segments.
Jharkhand has cleared a major step toward modernizing its public health system with the adoption of AI in healthcare, alongside a collaboration with Google to strengthen its digital backbone. The move is aimed at improving diagnostics, managing...
Global pharma giant AstraZeneca has achieved a major milestone with the Breztri Aerosphere asthma FDA approval, expanding treatment options for asthma patients worldwide. The U.S. Food and Drug Administration (FDA) has approved the..
As India’s healthcare sector undergoes rapid transformation driven by policy reforms, digital health initiatives, and increasing focus on quality and accessibility, the need for skilled professionals with strong managerial and leadership...
Dr. Reddy's Laboratories has secured a key regulatory win as its semaglutide injection receives approval from Health Canada, marking a major step in the global rollout of lower-cost alternatives to blockbuster diabetes and weight-loss drugs.
Aurigene Pharmaceutical Services is set to invest nearly $100 million investment to expand its CRDMO business, strengthening its role in the growing pharmaceutical outsourcing market.
Pfizer has reached agreements with several generic drug manufacturers that will allow its heart medicine Vyndamax to remain free from generic competition in the United States until 2031. The move gives the company more time to maintain stron...
Artificial intelligence-focused biotech company Profluent has partnered with pharmaceutical major Eli Lilly and Company in a genetic medicine deal worth up to $2.25 billion. The collaboration aims to develop advanced gene-editing therapi...
India stands at the heart of the Oxford malaria vaccine pact, as the Serum Institute of India joins hands with the University of Oxford to push forward a next-generation malaria vaccine candidate, R78C. The partnership puts India in a key...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")